Cover Image
Read Now

Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Preservative-free latanoprost (Monoprost) is available as a sterile ophthalmic solution in a single-dose container (50 mcg/mL). Health Canada approved Monoprost for the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OH) or open-angle glaucoma (OAG). The manufacturer is...

Full description

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) CADTH 2018, May 2018
Series:CADTH common drug review
Subjects:
Canada
Ocular Hypertension / Drug Therapy
Latanoprost / Therapeutic Use
Glaucoma, Open-angle / Drug Therapy
Cost-benefit Analysis
Latanoprost / Economics
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:Preservative-free latanoprost (Monoprost) is available as a sterile ophthalmic solution in a single-dose container (50 mcg/mL). Health Canada approved Monoprost for the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OH) or open-angle glaucoma (OAG). The manufacturer is requesting that Monoprost be reimbursed as per the Health Canada-approved indication. The recommended dose is one drop in the affected eye(s) once daily. The manufacturer-submitted price was $20.54 per pack of 30 single-use containers, corresponding to a price of $0.68 per day
Item Description:"Version. Final."
Physical Description:1 PDF file (37 pages) illustrations

Similar Items